Literature DB >> 10912930

Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinomas.

M Fujiwara1, I Okayasu, T Takemura, I Tanaka, R Masuda, Y Furuhata, M Noji, M Oritsu, M Kato, M Oshimura.   

Abstract

Telomerase activity was examined by the telomeric repeat amplification protocol assay in 25 cases of lung adenocarcinoma, in relation to cancer cell differentiation, proliferation, and chromosome alterations. Telomerase activity, chromosome alterations, and cell proliferation assessed by Ki-67 labeling were significantly lower (P < .001 to .05) in well-differentiated (10 cases) than in moderately differentiated (8 cases) or poorly differentiated (7 cases) lesions. Telomerase activity by semiquantitative analysis with scoring of 0 to 3 was significantly correlated with similarly graded chromosome alterations (P < .05) and Ki-67 labeling indices (P < .002). Telomerase activity and chromosome alteration (T-C) indices generated by multiplication of telomerase activity and chromosome alteration scores also showed a significant correlation with cell differentiation. The Clara cell subtype, confirmed by electron microscopic analysis, significantly predominated in the well-differentiated group, showing a low grade of telomerase activity and chromosome alterations and low Ki-67 labeling indices, suggesting clinical relevance. No significant association of telomerase activity was found with p53 protein accumulation or Bcl-2 protein expression. The good correlation of telomerase activity with chromosome alterations, cell differentiation, and Ki-67 labeling indices suggests that this parameter might have potential application in estimation of prognosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912930     DOI: 10.1038/modpathol.3880125

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.

Authors:  Yan Liu; Bing-quan Wu; Hao-hao Zhong; Xin-xia Tian; Wei-gang Fang
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

2.  Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma.

Authors:  Azin Mirzazadeh; Majid Kheirollahi; Ehsan Farashahi; Fatemeh Sadeghian-Nodoushan; Mohammad Hasan Sheikhha; Behrouz Aflatoonian
Journal:  Adv Biomed Res       Date:  2017-06-27

3.  Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Authors:  S Lantuejoul; J C Soria; D Moro-Sibilot; L Morat; S Veyrenc; P Lorimier; P Y Brichon; L Sabatier; C Brambilla; E Brambilla
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

4.  Association between hTERT rs2736100 polymorphism and sensitivity to anti-cancer agents.

Authors:  Julie Kim; Yava L Jones-Hall; Rongrong Wei; Jamie Myers; Yuan Qi; Gregory T Knipp; Wanqing Liu
Journal:  Front Genet       Date:  2013-08-26       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.